tiprankstipranks
BriaCell Therapeutics Corp (BCTX)
NASDAQ:BCTX
US Market
BCTX
BriaCell Therapeutics
RESEARCH TOOLSreports

BriaCell Therapeutics (BCTX) Financial Statements

329 Followers

BriaCell Therapeutics Financial Overview

BriaCell Therapeutics's market cap is currently $23.96M. The company's EPS TTM is $-27.61; its P/E ratio is -0.65; BriaCell Therapeutics is scheduled to report earnings on June 9, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 25Jul 24Jul 23Jul 22Jul 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -107.93KC$ 0.00C$ 0.00C$ 0.00C$ -15.55K
Operating IncomeC$ -27.54MC$ -33.33MC$ -23.27MC$ -15.29MC$ -7.11M
EBITDAC$ -27.43MC$ -4.85MC$ -23.26MC$ -26.82MC$ -7.10M
Net IncomeC$ -26.63MC$ -4.79MC$ -20.30MC$ -26.84MC$ -13.82M
Balance Sheet
Cash & Short-Term InvestmentsC$ 17.93MC$ 862.09KC$ 21.25MC$ 41.04MC$ 57.27M
Total AssetsC$ 21.72MC$ 5.87MC$ 27.16MC$ 42.58MC$ 58.04M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 25.99K
Net DebtC$ -10.53MC$ -862.09KC$ -21.25MC$ -41.04MC$ -57.24M
Total LiabilitiesC$ 4.33MC$ 8.56MC$ 30.94MC$ 32.25MC$ 30.37M
Stockholders' EquityC$ 17.94MC$ -2.38MC$ -3.78MC$ 10.33MC$ 27.67M
Cash Flow
Free Cash FlowC$ -28.51MC$ -24.58MC$ -23.74MC$ -12.48MC$ -7.75M
Operating Cash FlowC$ -28.51MC$ -24.13MC$ -23.74MC$ -12.48MC$ -7.75M
Investing Cash FlowC$ -7.74MC$ -681.80KC$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 46.00MC$ 4.42MC$ 3.95MC$ -3.74MC$ 65.00M
Currency in CAD

BriaCell Therapeutics Earnings and Revenue History

Income Statement >

BriaCell Therapeutics Debt to Assets

Balance Sheet >

BriaCell Therapeutics Cash Flow

Cash Flow >

BriaCell Therapeutics Forecast EPS vs Actual EPS

Earnings >